Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neurofibromatosis 1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05119582
What this trial is testing

HIFU Treatment of Cutaneous Neurofibromas in Neurofibromatosis Type 1: Safety and Efficacy

Who this might be right for
Cutaneous Neurofibroma
Joergen Serup 20
Testing effectiveness (Phase 2)Looking for participantsNCT05735717
What this trial is testing

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Who this might be right for
Hematologic MalignancyAcute LeukemiaRemission+21 more
Masonic Cancer Center, University of Minnesota 70
Testing effectiveness (Phase 2)Study completedNCT03326388
What this trial is testing

Intermittent Dosing Of Selumetinib In Childhood NF1 Associated Tumours

Who this might be right for
Neurofibromatosis Type 1Plexiform NeurofibromaOptic Nerve Glioma
Great Ormond Street Hospital for Children NHS Foundation Trust 14
Testing effectiveness (Phase 2)Ended earlyNCT02177825
What this trial is testing

Study of Imatinib Mesylate in Neurofibromatosis Type I Patients Aged 2 to 21 With Plexiform Neurofibromas

Who this might be right for
Plexiform Neurofibromas
St. Justine's Hospital 5
Not applicableApproved For MarketingNCT03259633
What this trial is testing

An Intermediate Access Protocol for Selumetinib for Treatment of Neurofibromatosis Type 1

Who this might be right for
NF type1 With Inoperable Plexiform Neurofibromas
AstraZeneca
Testing effectiveness (Phase 2)WithdrawnNCT05825365
What this trial is testing

Selumetinib in Chinese Paediatric With Post-operative NF1-PNs, PhaseⅡ, Double-Blinded, Placebo-Controlled Study

Who this might be right for
Neurofibromatosis Type 1Plexiform NeurofibromasPost-operative
AstraZeneca
Not applicableStudy completedNCT02153931
What this trial is testing

Internet Support Group for Parents of a Child With Neurofibromatosis Type 1

Who this might be right for
Neurofibromatosis 1
National Cancer Institute (NCI) 33
Testing effectiveness (Phase 2)Study completedNCT02332902
What this trial is testing

Everolimus for Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis1 CRAD001CUS232T

Who this might be right for
Neurofibromatosis 1
The University of Texas Health Science Center, Houston 24
Testing effectiveness (Phase 2)Looking for participantsNCT04374305
What this trial is testing

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)

Who this might be right for
Neurofibromatosis Type 2Vestibular SchwannomaNon-vestibular Schwannoma+2 more
Scott R. Plotkin, MD, PhD 109
Not applicableStudy completedNCT00006435
What this trial is testing

Study of Plexiform Neurofibromas in Neurofibromatosis Type 1

Who this might be right for
Plexiform NeurofibromasNF1
National Cancer Institute (NCI) 24
Not applicableUnknownNCT03518710
What this trial is testing

Vision, Attention and Reading in Neurofibromatosis Type 1 (NF1) Children

Who this might be right for
Neurofibromatosis Type 1
University Hospital, Toulouse 15
Testing effectiveness (Phase 2)Ended earlyNCT01968590
What this trial is testing

Vitamin D Supplementation for Adults With Neurofibromatosis Type 1 (NF1)

Who this might be right for
Neurofibromatosis Type 1 (NF1)
University of Utah 26
Not applicableNot Yet RecruitingNCT07077408
What this trial is testing

ICanCope With NF: Innovating an Efficacious Digital Self-management and Transitional Care Program for Adolescents With Neurofibromatosis

Who this might be right for
Neurofibromatosis 1
The Hospital for Sick Children 60
Not applicableStudy completedNCT07327164
What this trial is testing

Precision Medicine for Neurocutaneous Syndromes in Western China

Who this might be right for
Neurocutaneous SyndromesNeurofibromatosis Type 1 (NF1)Tuberous Sclerosis Complex (TSC)+2 more
West China Hospital 1,200
Testing effectiveness (Phase 2)Ended earlyNCT05011019
What this trial is testing

A Clinical Trial to Evaluate the Safety and Efficacy of AL2846 Capsules in Chinese Patients With Type I Neurofibromatosis

Who this might be right for
Neurofibromatosis and Malignant Peripheral Nerve Sheath Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 22
Testing effectiveness (Phase 2)Ended earlyNCT03504501
What this trial is testing

Synaptic Plasticity and Cognitive Function in RASopathies

Who this might be right for
Impaired Synaptic PlasticityImpaired Cognition
Technical University of Munich 16
Not applicableStudy completedNCT00667836
What this trial is testing

Multi-center Project: Spinal Abnormalities in Neurofibromatosis Type1 (NF1) Patients

Who this might be right for
Neurofibromatosis Type 1
Shriners Hospitals for Children 300
Early research (Phase 1)Active Not RecruitingNCT04590235
What this trial is testing

Selumetinib in Chinese Paediatric and Adult Subjects With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN)

Who this might be right for
Neurofibromatosis 1Neurofibroma Plexiform
AstraZeneca 32
Not applicableLooking for participantsNCT04395495
What this trial is testing

RASopathy Biorepository

Who this might be right for
RAS MutationNeurofibromatosis 1Noonan Syndrome+11 more
Children's Hospital Medical Center, Cincinnati 1,000
Large-scale testing (Phase 3)Ended earlyNCT00427583
What this trial is testing

Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors

Who this might be right for
Malignant Peripheral Nerve Sheath Tumors
Novartis Pharmaceuticals 11
Next Page